[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone

C129H133F4N27O6 — CID 158874858

IUPAC[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone
SMILESCC12CC(C(=O)N3N=CCC3c3ccccc3)(C1)C2.CC1=NN(C(=O)C23CC(Cn4cc(C)cn4)(C2)C3)C(c2cc(F)cc(F)c2)C1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnc(C)cn4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cncc(C)n4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnccn4)(C2)C3)c1.O=C(N1CC(F)CC1c1cccc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2
InChIInChI=1S/C24H23F2N3O.2C23H24N6O.C22H22N6O.C21H22F2N4O.C16H18N2O/c25-18-6-3-5-16(8-18)21-9-19(26)11-28(21)22(30)24-12-23(13-24,14-24)15-29-20-7-2-1-4-17(20)10-27-29;1-15-3-4-19-17(7-15)9-27-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-26-29)18-10-24-16(2)8-25-18;1-15-3-4-19-17(7-15)9-26-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-25-29)18-10-24-8-16(2)27-18;1-15-2-3-18-16(8-15)9-26-27(18)14-21-11-22(12-21,13-21)20(29)28-19(4-5-25-28)17-10-23-6-7-24-17;1-13-7-24-26(8-13)12-20-9-21(10-20,11-20)19(28)27-18(3-14(2)25-27)15-4-16(22)6-17(23)5-15;1-15-9-16(10-15,11-15)14(19)18-13(7-8-17-18)12-5-3-2-4-6-12/h1-8,10,19,21H,9,11-15H2;2*3-4,6-10,20H,5,11-14H2,1-2H3;2-3,5-10,19H,4,11-14H2,1H3;4-8,18H,3,9-12H2,1-2H3;2-6,8,13H,7,9-11H2,1H3
InChIKeyJCHPCPZQTPONHT-UHFFFAOYSA-N
MW2233.66 g/mol
LogP22.19
Rot. Bonds22

About [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone

[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone (PubChem CID 158874858) has the molecular formula C129H133F4N27O6 and a molecular weight of 2233.66 g/mol. Its IUPAC name is [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone.

Molecular Properties

Compound Name[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone
PubChem CID158874858
Molecular FormulaC129H133F4N27O6
Molecular Weight2233.66 g/mol
Exact Mass2232.09
IUPAC Name[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone
SMILESCC12CC(C(=O)N3N=CCC3c3ccccc3)(C1)C2.CC1=NN(C(=O)C23CC(Cn4cc(C)cn4)(C2)C3)C(c2cc(F)cc(F)c2)C1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnc(C)cn4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cncc(C)n4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnccn4)(C2)C3)c1.O=C(N1CC(F)CC1c1cccc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2
InChIInChI=1S/C24H23F2N3O.2C23H24N6O.C22H22N6O.C21H22F2N4O.C16H18N2O/c25-18-6-3-5-16(8-18)21-9-19(26)11-28(21)22(30)24-12-23(13-24,14-24)15-29-20-7-2-1-4-17(20)10-27-29;1-15-3-4-19-17(7-15)9-27-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-26-29)18-10-24-16(2)8-25-18;1-15-3-4-19-17(7-15)9-26-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-25-29)18-10-24-8-16(2)27-18;1-15-2-3-18-16(8-15)9-26-27(18)14-21-11-22(12-21,13-21)20(29)28-19(4-5-25-28)17-10-23-6-7-24-17;1-13-7-24-26(8-13)12-20-9-21(10-20,11-20)19(28)27-18(3-14(2)25-27)15-4-16(22)6-17(23)5-15;1-15-9-16(10-15,11-15)14(19)18-13(7-8-17-18)12-5-3-2-4-6-12/h1-8,10,19,21H,9,11-15H2;2*3-4,6-10,20H,5,11-14H2,1-2H3;2-3,5-10,19H,4,11-14H2,1H3;4-8,18H,3,9-12H2,1-2H3;2-6,8,13H,7,9-11H2,1H3
InChIKeyJCHPCPZQTPONHT-UHFFFAOYSA-N
XLogP22.19
TPSA350.10 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds22
Heavy Atoms166
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002233.66
LogP ≤ 522.19
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone?
The IUPAC name of [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone (CID 158874858) is [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone.
What is the SMILES notation for [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone?
The canonical SMILES for [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone is CC12CC(C(=O)N3N=CCC3c3ccccc3)(C1)C2.CC1=NN(C(=O)C23CC(Cn4cc(C)cn4)(C2)C3)C(c2cc(F)cc(F)c2)C1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnc(C)cn4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cncc(C)n4)(C2)C3)c1.Cc1ccc2c(cnn2CC23CC(C(=O)N4N=CCC4c4cnccn4)(C2)C3)c1.O=C(N1CC(F)CC1c1cccc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2.
What is the InChIKey of [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone?
The InChIKey is JCHPCPZQTPONHT-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23F2N3O.2C23H24N6O.C22H22N6O.C21H22F2N4O.C16H18N2O/c25-18-6-3-5-16(8-18)21-9-19(26)11-28(21)22(30)24-12-23(13-24,14-24)15-29-20-7-2-1-4-17(20)10-27-29;1-15-3-4-19-17(7-15)9-27-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-26-29)18-10-24-16(2)8-25-18;1-15-3-4-19-17(7-15)9-26-28(19)14-22-11-23(12-22,13-22)21(30)29-20(5-6-25-29)18-10-24-8-16(2)27-18;1-15-2-3-18-16(8-15)9-26-27(18)14-21-11-22(12-21,13-21)20(29)28-19(4-5-25-28)17-10-23-6-7-24-17;1-13-7-24-26(8-13)12-20-9-21(10-20,11-20)19(28)27-18(3-14(2)25-27)15-4-16(22)6-17(23)5-15;1-15-9-16(10-15,11-15)14(19)18-13(7-8-17-18)12-5-3-2-4-6-12/h1-8,10,19,21H,9,11-15H2;2*3-4,6-10,20H,5,11-14H2,1-2H3;2-3,5-10,19H,4,11-14H2,1H3;4-8,18H,3,9-12H2,1-2H3;2-6,8,13H,7,9-11H2,1H3.
What are the key properties of [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone?
[3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone has a molecular weight of 2233.66 g/mol, XLogP of 22.19, 22 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(3,5-difluorophenyl)-5-methyl-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;(3-methyl-1-bicyclo[1.1.1]pentanyl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-[3-(6-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone;[3-[(5-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]-(3-pyrazin-2-yl-3,4-dihydropyrazol-2-yl)methanone is sourced from PubChem (CID 158874858), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).